Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered NimodipineNew Drug Application ...

In recent years, the broader technology sector has often been the driving force behind market growth. However, at the start ...

Microsoft Threat Intelligence observed limited activity by an unattributed threat actor using a publicly available, static ...

Sophos has observed cybercriminals ramping up their use of graphics files as part of email phishing attacks to bypass ...

Our zLabs research team has discovered a mobile malware campaign consisting of almost 900 malware samples primarily targeting ...

CyberArk (CYBR) announced a new integration with SentinelOne (S) AI-powered cybersecurity platform, SentinelOne Singularity, to protect against ...